Sportswear firm Skechers (SKX) Thursday said its revenues rose to a record high in the third quarter. Earnings declined modestly, but to a lesser extent compared to analysts’ forecast. The stock gained about 7% during the extended trading hours as the market responded positively to the results and upbeat outlook.
Net income dropped to $90.7 million or $0.58 per share from $92.3 million or $0.59 per share a year earlier, but exceeded market expectations.
During the quarter, sales jumped 7.5% annually to a record high of $1.18 billion, amidst double-digit growth in both retail and wholesale sales. The top-line also surpassed estimates. Comparable store sales rose 1.9% in the third quarter when a 3% growth in the US sales more than offset a 0.8% decline in the overseas market.
“Both our domestic and international businesses grew, and we remained the leader in walking, work, casual lifestyle and sandals footwear in the United States. We experienced strong product successes across multiple divisions around the world, which was evident by our double-digit growth in both our international wholesale and worldwide Company-owned retail businesses,” said CEO Robert Greenberg.
Looking ahead, Skechers expects sales in the range of $1.1 billion to $1.125 billion and earnings per share between $0.20 and $.25 for the fourth quarter, when all the three operating segments are expected to register growth. The effective tax rate for the quarter is estimated between 13% and 15%. It is anticipated that full-year sales would reach a new record high.
The ongoing investment in infrastructure is expected to provide the company with a significant opportunity to grow the brand further through wholesale, company-owned stores and third-party outlet, said the statement. Skechers repurchased about 1.4 million common shares for $40.0 million during the September quarter.
The stock plunged 31% since the beginning of the year. It closed Thursday’s regular session lower but gained 7% in the after-market following the earnings report.
Listen to publicly listed companies earnings conference calls along with the edited closed caption text
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
